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Incubation of intact hepatocytes with either of the synthetic diacyl glyccrols I-oleoyl-2-acetyl glycerol (OAG) or dihexanoyl glycerol (DHG) caused 
the transient uncoupling of the ability of glucagon to stimulate adenylate cyclase in membranes prepared from those cells. No change occurred 
in either the activity of the catalytic unit of adenylate cyclase or the coupling of G, to adenylate cyclase. Diacyl glycerol action appeared to mimic 
glucagon-mediated esensitization of adenylate cyclase, suggesting that protein kinase C activation may provide the molecular trigger for glucagon 
desensitization. 
Desensitization; Adenylate cyclase; Diacyl glycerol; Protein kinase C: Glucagon; Guanine nucleotide regulatory protein 
1. INTRODUCTION have been shown [14-171 to elicit a stimulation, albeit 
rather small, of inositol phospholipid metabolism. 
In many systems the challenge of cells with an agonist In this study we examine the effect of treatment of 
for a specific receptor can lead to the desensitization of intact hepatocytes with synthetic diacyl glycerols upon 
the biological response. This appears to play an impor- specific facets of adenylate cyclase activity and show 
tant control in modu!ating cellular signal transduction that they closely mimic the ability of glucagon to effect 
processes and a variety of different molecules can be the ‘uncoupling’ or desensitization of this key regula- 
used to achieve such regulation [l-4]. tory enzyme. 
We [4-61 and others [7-l 1] have shown that challenge 
of hepatocytes with glucagon gives rise to the rapid 
desensitization of adenylate cyclase activity. This is evi- 
dent from both the transience of the increase in intracel- 
lular cyclic AMP concentration that ensues and also 
from the decreased ability of glucagon to stimulate ade- 
nylate cyclase in membranes derived from glucagon- 
treated cells. The ability of glucagon to elicit the desen- 
sitization of adenylate cyclase appears to be a cyclic 
AMP-independent phenomenon [4-6,10-l 21. This is 
most clearly shown by the ability of TH-glucagon, an 
analogue of glucagon which is incapable of activating 
adenylate cyclase, to elicit desensitization in intact hepa- 
tocytes [6]. We have suggested [6] that the molecular 
mechanism underlying the ability of glucagon to de- 
sensitise adenylate cyclase might be related to the diacyl 
glycerol- catalysed activation of protein kinase C as 
glucagon can increase intracellular diacylglycerol con- 
centrations [13] and both glucagon and TH-glucagon 
2. MATERIALS AND METHODS 
Collagenase. CAMP and ATP and all other nucleotides were pur- 
chased from Boehringer (UK). Lewes, East Sussex UK. 3-Isobutyl-l- 
methylxanthine (IBMX) was from Aldrich. Gillingham. Dorset. UK 
Forskolin (7-B-acetoxy-8.13-epox~lu.6~.9Y-trihydrolased-l4-cn-l I- 
one) was from Calbiochem. Glucagon was kindly given by Dr W.W. 
Bromer of Eli Lilly and Co.. Indianapolis. IN. USA. Dihexanoyl 
glycerol (DMG) was kindly given by Dr L. Garland. Wcllcome Foun- 
dation Ltd., Bekenham, UK. I-Oleoyl-2-acetyl-glycerol (OAG) was 
obtained from Sigma, Poole, Dorsct. UK. All other biochemicals were 
from Sigma. Radiochemicals were obtained from Amersham Interna- 
tional, Amersham. Bucks, UK. All other chemicals were of AnalaR 
grade, from BDH Chemicals. Poole. Dorset. 
DGH was dissolved in chloroform to give a stock solution of 300 
pglml with further dilutions being carried out in IO mM glucose/2.5 
g BSAIOO ml 2.5 mM Ca”-containing Krebs-Henselcit buffer. OAG 
was suspended in a 1% solution of dimethylsulfoxide (DMSOI to give 
a stock solution of 30 pg/rnl which was sonicated for 30 min before 
any further dilutions were carried out using distilled water. 
Isolated hepatocytes were prepared [I 8.191 from fed 225-250 g male 
Sprague-Dawley rats and pm-incubated as previously described [5] at 
37°C for 20 min with gassing using CO,IOz (19:l) and at 15 min 
intervals during the experiments. Ligands were added to the reaction 
vessel in a volume which was less than 1% of the total incubation 
volume. After !hc cppropriatc time interval. samples were removed as 
before [S] and the cells were quenched by adding an equal volume of 
ice-cold I mM KHCO>, pH 7.2: and then placing them on ice. All 
subsequent procedures were performed at 4°C. 
Abbreviuiiorrs: OAG, I-oleoyl-2-acetyl glycerol; DHG. dihexanoyl 
glycerol 
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us [S]. In all cases membranes. which were kept on ice. !vere used 
within 2 h of their preparation. Thecyclic AMP produced was assessed 
in a binding assay using the cyclic AMP-binding subunit of protein 
kinase prepared from bovine heart as before [5]. The activities cxpres- 
sed reflect the accumulation of CAMP over a IO min period of assay 
at 3ooc. 
Adenylate cyclase assays were performed at 30°C as described in 
detail previously by us [20]. Final concentrations of stimulatory iig- 
ands were added as stated in the legends and text. Initial rates were 
taken From linear timecourses. 
3. RESUeTS AND DISCUSSION 
Various investigators [I O-1 21. including ourselves [4- 
6]. have shown that glucagon elicits the desensitization 
of adenylate cyclase activity in intact rat hepatocytes 
through a cyclic AMP-independent process. This does 
not ensue as a result of receptor loss but. rather. is due 
to the uncoupling of the glucagon receptor from the 
stimulatory G-protein, G, [4]. This process can be mi- 
micked by hormones such as vasopressin and angioten- 
sin [6]. which stimulate inositol phospholipid metabo- 
lism. And. as glucagon has been shown capable of elici- 
ting a small activation of this pathway [14-171 and the 
production of diacylglycerol [ 131. we have suggested [6] 
that desensitization might be caused through the action 
of protein kinase C. Certainly. this enzyme has been 
shown to attenuate the functioning of a variety of recep- 
tors. including G-protein-linked ones, by effecting their 
phosphorylation [4] and is activated upon an increase 
in intracellular diacylglycerol concentrations [21]. In- 
deed, we were able to demonstrate that incubation of 
intact hepatocytes with either OAG or DHG led to an 
apparent desensitization of adenylate cyclase (fig. la). 
This was readily apparent from the diminished ability 
of glucagon to stimulate ad.enylate cyclase activity in a 
washed membrane fraction derived from OAG-treated 
cells. The action of OAG was, as with glucagon treat- 
ment or hepatocytes [5.6], limited to the uncoupling of 
the receptor from stimulation of adenylate cyclase. This 
is clearly evident from data showing that the functio- 
ning of the catalytic unit of adenylate cyclase. as asses- 
sed by determining basal activity of that stimulated by 
forskolin. was unaltered when assessed in membranes 
from treated cells (Table I). 
Similarly, coupling of G, to adenylatc cyclase. as as- 
sessed by stimulation with NaF. was unaltered (Table 
I}. Similar results were obtained with DHG. although 
the rate of uncoupling (desensitization) and its magni- 
tude were far greater (Fig. 1 a). This may reflect differen- 
ces in the rates of entry and metabolism of the two 
synthetic diacylgIycerols as well as differences in their 
potency and, selectivity in activation of protein kinase 
C isoforms. In both instances, however, maximal effects 
were exerted after around 20 min. This was followed by 
a subsequent reversal, with resensitization occurring 
after a further 20 min (Fig. la). We feel that this resen- 
sitization is unlikely to be due to the metabolism of 
diacylgiycerol as the rate seen was unaltered using DAG 
concentrations some IO-fold greater than those em- 
ployed to obtain the data shown on Fig. 1. Thus we 
Table I 
Adcnylatc cyclasc activity in mcmbrancs from control and diacylglyccrol-treated hcpatocytes 
Ligand addition 
Adcnylatc cyclasc activity fpmoliminlmg protein) 
Ccl1 prc-treatment 
Di-octanoyl glycerol 
(I5 ngiml for 20 min) 
None (basal) 
I.8 t 0.3’ 
Forskolin 
63.8 I! 5.2’ 
NaF 
48.7 + 6.3’ 
Giucagon + GTP 
19.2 t 2.9” 
(69.8%) 
Di-hexanoyl glycerol 
(I5 n&ml for 20 min) 2.2 + 0.2’ 56.4 t 3.2- 52.1 c 3.6’ X.4 I! 3.6”’ 
(30.5%) 
None (control) 1.9 2 0.1 5x.2 + 6.5 54.2 5 6.2 27.5 + 2.6 
(100%) 
Glucagon 
(IO nM for 5 min) 2.0 f 0.2’ 61.0 + 4.1’ 4x.3 + 5.8_ 8.6 I! l.Z-” 
(31.3%) 
Hcpatocyte membranes wcrz assayed for adcnylatc cyclasc activity in either the absence ofany stimulatory ligand (basal activity) or in the prcscncc 
of forskolin (IOeJ M), NaF (I 5 nM) or glucagon (IO nM) togcthcr with GTP (IO j[M). Membranes were prepared from control cells or those 
pm-treated with either di-hcxanoyl glycerol or di-octanoyl glycerol or glucagon as indicated above. Activity. in the presence of glucagon + GTP, 
is shown in parcnthcscs also as a pcrccntagc of that found for the untrcatcd cells. ‘not significantly different from activities found in membranes 
l’rom control (non prc-trcamd) cells; “P is less than 0.01; “‘I’ is less than 0.001. Student’s I-test for )1=6 cxperimcnts using different mcmbrartc 
preparations (errors arc SD of means). 
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Fig. I. Desensitization of glucagon-stimulated adenylate cyclasc by synthetic diacylglycerols. (a) Shows a timecourse for the inactivation of 
(glucagon (10 nM) + GTP (lObM))-stimulated adenylate cyclase activity in membranes from hcpatocytcs treated witb either (m)di-hexanoyl glycerol 
(IO ng/ml) or (0) di-octanoyl glycerol (IO nJmI). (b) Shows a dose-effect curve for the inactivation of (glucagon + GTP)-stimulated adenylate cyclasc 
activity in membranes from hepatocytes treated for IO min with either di-hcxanoy[ glycerol (@ or di-octancyl glycerol (r). Experiments wcrc done 
three times (,1=3) using triplicate determinations of adcnylate cyclase activity. Errors arc SD *significant at P is less than 0.01 and **significant 
at P is less than 0.001 (Student’s t-test). 
believe that a separate resensitization process may be 
invoked as suggested before by us for glucagon [7]. 
Indeed, in the case ofglucagon. desensitization wasmax- 
imal after about 5 min. achieved levels comparable to 
that seen with DHG (Table I) and full resensitization 
was similarly obtained some 20 min after maximal de- 
sensitization [5-71. 
The desensitization of glucagon-stimulated adenylate 
cyclase activity was dose-dependent with respect to both 
of the two synthetic diacylglycerols (Fig. lb). In each 
instance, potencies were similar, yielding half-maximal 
effects at 2 & 1 @ml OAG and 3 + 1 ng/ml DHG (n=3 
determinations; errors are SD). 
These data are consistent with the notion [6] that it 
is the activation of protein kinase C by diacylglycerol 
that provides the trigger for glucagon desensitization in 
hepatocytes. Although this may be potentiated by the 
well-established rise in intracellular Ca” that glucagon 
elicits in hepatocytes by both cyclic AMP-independent 
and -dependent mechanism (see [22]). It is. unfortuna- 
tely. not possible to test this by attempting to doU,vvn- 
regulate protein kinase C using chronic exposure to the 
phorbol ester TPA as, in culture, primary hepatocytes 
begin to dedifferentiate and show alterations in and 
then loss of the ability of cyclase to be regulated nor- 
mally by glucagon. The source of such diacylglycerol 
remains to be established: perhaps derived from the 
small stimulation cf inositol phospholipid metabolism 
by glucagon. which has been noted, although there is 
the possibility that it could be sourced, in part, from the 
breakdown of phosphatidyl choline as ha.s been noted 
recently for a variety of hormones [23]. It would appear 
from this and other studies (see [4]) that receptor-media- 
ted diacylglycerol production and the activation of pro- 
tein kinase C may play a pervasive role in modulating 
cellular responsiveness through altering adenylate cy- 
clase functioning. 
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